Califf: Sponsors Should Go Beyond Letter Of Law With Trial Diversity Plans

 
• By Sarah Karlin-Smith
  
diverse group of people with hands in the middle
FDA Commissioner Robert Califf said trial diversity will improve through analysis of trial diversity plans. (Shutterstock)

More from Diversity & Inclusion

More from R&D